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Abstract
Background: The human QKI gene, called quaking homolog, KH domain RNA binding (mouse), is a candidate gene for
schizophrenia encoding an RNA-binding protein. This gene was shown to be essential for myelination in oligodendrocytes.
QKI is also highly expressed in astrocytes, but its function in these cells is not known.
Methods/Principal Findings: We studied the effect of small interference RNA (siRNA)-mediated QKI depletion on global
gene expression in human astrocyte glioma cells. Microarray measurements were confirmed with real-time quantitative
polymerase chain reaction (qPCR). The presence of QKI binding sites (QRE) was assessed by a bioinformatic approach.
Viability and cell morphology were also studied. The most significant alteration after QKI silencing was the decreased
expression of genes involved in interferon (IFN) induction (P=6.3E-10), including IFIT1, IFIT2, MX1, MX2, G1P2, G1P3, GBP1
and IFIH1. All eight genes were down-regulated after silencing of the splice variant QKI-7, but were not affected by QKI-5
silencing. Interestingly, four of them were up-regulated after treatment with the antipsychotic agent haloperidol that also
resulted in increased QKI-7 mRNA levels.
Conclusions/Significance: The coordinated expression of QKI-7 splice variant and IFN-related genes supports the idea that
this particular splice variant has specific functions in astrocytes. Furthermore, a role of QKI-7 as a regulator of an
inflammatory gene pathway in astrocytes is suggested. This hypothesis is well in line with growing experimental evidence
on the role of inflammatory components in schizophrenia.
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Introduction
QKI protein is a member of the STAR (Signal Transduction
and Activation of RNA) family [1]. This family of proteins
contains an RNA binding domain called KH [2]. In particular, the
KH domain of QKI is extremely conserved among different
species, and binds selectively to cellular messenger RNAs [3],
many of which contain a specific QKI response element (QRE)
[4]. In other words, QKI post-transcriptionally regulates expres-
sion of several RNAs by directly binding to them at QRE sites.
There are three major splice variants called QKI-5, QKI-6 and
QKI-7 that encode different protein isoforms.
QKI has been proposed as a candidate gene for schizophrenia
after several lines of evidence including linkage analysis [5,6] and
mRNA expression studies [6,7,8]. Although decreased QKI
expression in the brain of schizophrenia patients has been shown
by several groups, the nature of the cells with reduced expression,
and the physiological effect in the brain of patients is not known.
Previous research efforts concentrated on the study of QKI
function in oligodendrocytes because multiple lines of evidence
implicate this cell type in schizophrenia [9,10,11,12]. Indeed, the
QKI protein has been shown not only to be necessary, but also
sufficient to promote differentiation of oligodendrocytes into
myelinating cells in rats [13]. However, all three QKI proteins
are highly expressed in all glial cells in mice, including not only
oligodendrocytes but also astrocytes [14], which are the most
abundant glial cells in the brain [15]. Moreover, a role of
astrocytes in schizohrenia has been already proposed based on
several lines of evidence [16,17,18,19,20,21,22].
In order to study the role of QKI in astrocytes, we used small
interference RNA (siRNA) designed to suppress the expression of
specific QKI splice variants in human astrocyte glioma cells, and
studied the effect of silencing on global gene expression.
Results
Silencing the expression of QKI-tot, QKI-5 and QKI-7 in
human glial cell lines
Astrocyte glioma cells were treated with three different pools of
siRNA designed to silence all QKI splice variants (QKI-tot), or
only splice variant QKI-5 or QKI-7 (Fig. 1A). QKI-6 sequence
does not contain splice-variant specific fragments that could be
used for siRNA design (Fig. 1A). The remaining expression levels
after silencing were measured by real-time RT-PCR (Fig. 1B). The
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cells treated with the siRNA that targets all transcripts, with less
than 10% of QKI expression levels remaining (Fig. 1B). The
siRNA for the splice variants 5 and 7 (siQKI-5 and siQKI-7)
reduced the corresponding splice variant. In addition, silencing of
QKI-5 also resulted in decreased expression of the other splice
variants (Fig. 1B), suggesting that QKI-5, which is located in the
nucleus, may affect mRNA levels of the other splice variants, that
are predominantly located in the cytoplasm [14]. In summary, we
were able to efficiently silence QKI in astrocyte glioma cells.
Global analysis of expression differences in QKI-Silenced
Glial Cell Lines
QKI is known to regulate RNA expression levels of multiple
genes and we reasoned that the silencing experiments should
modify mRNA expression patterns in the cells. To study this, we
used microarray analysis as described in the Methods. In total, 143
annotated genes were differentially expressed as shown in
Supplementary Table S1 (Table S1). The genes with altered
expression generated three gene groups, depending on whether
the cells were silenced with siQKI-tot, siQKI-5 or siQKI-7.
Detailed information such as gene names, fold changes, and
expression in patients (previously reported by others), are
summarized in Table S1. As a control, we repeated all siRNA
experiments in a human oligodendroglial cell line named HOG,
previously established by others [23].
GO and Ingenuity Analysis
To study whether the genes identified by microarray analysis
belonged to common pathways, we performed GO analysis on all
143 genes. Only one type of genes was overrepresented in the list
namely, immune related genes. In particular, the category formed
Figure 1. Small interference RNA (siRNA)-mediated depletion of QKI splice variants in astrocytoma (U343) cell lines. A. Exon-intron
structure of the quaking gene and the regions targeted by small interfering RNA. siQKI-tot was designed to suppress all QKI splice variants (QKI-tot),
siQKI-5 silences only splice variant 5 (QKI-5), and siQKI-7 silences splice variants 7 and 7b (QKI-7). The sequences included in each siRNA cocktail are
listed in Table 2. B. Percentage of remaining messenger RNA expression levels for QKI-tot, QKI-5 and QKI-7, are shown after silencing with siQKI-tot,
siQKI-5 or siQKI-7. Asterisk (*) indicates significant deviation in the mRNA levels compared with the untreated (CTL) groups (p-value ,0.05, ,0.01, and
,0.001 for one, two, and three asterisks, respectively). Mean and standard errors are given based on three biological replicates.
doi:10.1371/journal.pone.0013079.g001
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value 6.3E-10). Seven of total possible 37 genes (reported in the
database DAVID) identified in this category were altered (p-value
=8.18E-8). The 7 genes are listed in Table 1. Manual inspection
of the list of altered genes revealed one additional IFN induced
gene, IFIH1 that is not annotated in the DAVID database
(Table 1). Moreover, Ingenuity analysis demonstrated that these 8
genes, as well as many other genes affected by siQKI-7 silencing
(Table S1), were included in two major overlapping pathways
named ‘‘cell-mediated immune response’’ (score 30 in the
ingenuity analysis) and ‘‘cellular movement’’ (score 32). These
pathways are illustrated in Supplementary Figure S1 (Fig. S1).
None of these genes were affected in their expression levels after
silencing of QKI in an oligodendroglial cell line (Table S2). All
eight IFN-related genes were down-regulated after silencing of
QKI-7. These results indicate a very specific function for QKI-7
and suggest that this transcript may regulate IFN related genes in
astrocytes in vivo. The changed expression of these eight genes was
further validated by quantitative PCR, that confirmed down-
regulation for all eight genes after QKI-7 silencing (Fig. 2).
We have recently shown that haloperidol treatment specifically
increases QKI-7 in U343 cells [24]. In that study, we did not see
an effect of haloperidol in QKI-5 or QKI-6. In other words, the
haloperidol effect was splice variant specific [24]. Therefore, we
decided to investigate whether haloperidol treatment could reverse
the effect of QKI-7 silencing. Fig. 3 shows Real-Time PCR
analysis that demonstrates that haloperidol treatment partially
reversed the effect of QKI-7 silencing, since several IFN induced
genes were significantly increased in a coordinated way with QKI-
7 increase (Fig. 3).
QKI Response Element Analysis
To evaluate whether the genes with altered expression after
QKI silencing may be directly regulated due to QKI proteins
binding to them, the sequences of the complete set of 143 genes
were scanned for the presence of potential QRE binding sites as
described in the methods, and reported previously [4]. We first
performed a very stringent search for complete QREs, consisting
of at least a core site and a half site [4] and we found a significant
overrepresentation of these sites among genes altered by QKI
silencing compared with a random set of genes present on the
arrays (p,0.01, genes with complete QREs are indicated in Table
S1). In fact, four of the eight IFN-related genes down-regulated by
QKI-7 silencing contained at least one complete QRE (Table 1).
Then, we performed a more relaxed search for the presence of
QRE core sites without half sites [4]. In this case, many more of
the 143 genes were found to include potential QRE sites. For
example, all eight genes included in Table 1 contained at least one
core-binding site for QKI. Therefore, QKI proteins may directly
bind to all eight IFN-related genes.
Figure 2. Real-time qPCR experiments confirm decreased
mRNA Expression of Interferon-inducible genes in QKI-7
silenced U343 cells. Messenger RNA expression levels of IFIT1, IFIT2,
MX1, MX2, G1P2, G1P3, GBP1 and IFIH1, relative to reference gene
expression (ACTB and GAPDH) in QKI-7 silenced cells were measured by
real-time RT-PCR to confirm the results of microarray experiments. As a
control for the efficiency of silencing, the levels of QKI-7 were also
measured. The level in untreated cells is defined as zero. Asterisk (*)
indicates significant deviation in the mRNA levels compared with the
untreated cells (p-value ,0.05, ,0.01, and ,0.001 for one, two, and
three asterisks, respectively). Mean and standard errors are given based
on three biological replicates.
doi:10.1371/journal.pone.0013079.g002
Table 1. GO Classification.
Gene Symbol Fold Changes Bipolar
a Schizo
b QRE
c QRE
d
QKI-tot QKI-5 QKI-7 Core site Core + half site
IFIT1 1.0 21.2 25.3 21 212 2
IFIT2 1.0 1.3 24.3 21 211 1
MX2 1.1 21.0 23.5 21 211 0
MX1 1.0 1.1 22.6 0 211 0
G1P2 1.2 21.1 23.1 21 211 1
G1P3 1.3 1.0 22.9 00 10
GBP1 21.1 1.1 22.3 210 1 0
IFIH1 21.2 21.1 22.3 0 211 1
All 143 genes identified in microarray analysis were also submitted for GO classification as described in the Methods. The table includes expression results for the seven
genes included in the most significant GO category, interferon induction (p=8.18E-8) and one more interferon related gene, IFIH1, not annotated in the DAVID
database.
aExpression changes previously reported in postmortem brains from bipolar patients.
bExpression changes previously reported in postmortem brains from patients with schizophrenia.
Data for the columns ‘‘Bipolar’’ and ‘‘Schizo’’ was extracted from the database of Stanley brain bank (http://www.stanleyresearch.org/brain/): ‘‘21’’, decreased mRNA
expression (p value , 0.05); ‘‘1’’, increased mRNA expression (p value ,0.05); ‘‘0’’, no significant changes.
cNumber of core sites contained within the transcript of the genes included in the table.
dNumber of ‘‘complete QRE’’ contained within the transcript of the genes included in the table.
doi:10.1371/journal.pone.0013079.t001
QKI Regulates Interferon Genes
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e13079Cell viability and morphology
We analysed cell viability and morphology after QKI silencing
as described in the methods. No differences in viability were
observed after any of the siRNA treatments. Changes in
morphology were not observed after one day of treatment with
any of the siRNA cocktails. On the other hand, after eight days of
treatment, we detected a significantly increased ratio (p-value 0.02)
between cell body size and process length in QKI-5 silenced U343
cells (Fig. 4). Changes in ratio were a result of shorter cell process
length rather than larger cell bodies. In cells where QKI-7 was
silenced, no changes in the ratio between the cell body and process
length were detected after eight days of treatment.
Discussion
We found that siRNA-mediated reduction of QKI-7 resulted in
a dramatic down-regulation of well-known IFN induced genes in
an astrocytic cell line. This effect was not observed when the cells
were silenced with siQKI-tot. These results may seem counterin-
tuitive at first. In fact, siQKI-tot treatment resulted in a dramatic
decrease in expression of QKI-7 amongst the other QKI types.
However, the microarray results do not show any IFN mRNA
targets to be affected by siQKI-tot. These results are not
necessarily contradictory. In fact, current research suggests that
the balance or proportion between splice variants (rather than
changes in each splice variant per se) is important for tissue-
Figure 3. Increased mRNA Expression of Interferon-inducible
genes in haloperidol treated U343 cells. Messenger RNA
expression levels of IFIT1, IFIT2, MX1, MX2, G1P2, G1P3, GBP1 and
IFIH1, relative to reference gene expression (ACTB and GAPDH) were
measured after treatment of U343 cells with 0.2 uM haloperidol. As a
control for the efficiency of induction, the levels of QKI-7 were also
measured and shown to be increased. The level in untreated cells is
defined as zero. Asterisk (*) indicates significant deviation in the mRNA
levels compared with the untreated cells (p-value ,0.05, ,0.01, and
,0.001 for one, two, and three asterisks, respectively). Mean and
standard errors are given based on three biological replicates.
doi:10.1371/journal.pone.0013079.g003
Figure 4. Silencing of QKI-5 changes cell process length. The figure shows the cell process length in untreated (left) and siQKI-5silenced cells
(right) after eight days of treatment as described in the methods. The graph below the pictures shows the ratio between the cell body size and cell
process length in the untreated and treated cells calculated as described in the methods (p-value ,0.05). L indicates the left process, R indicates the
right process and C indicates the cell body.
doi:10.1371/journal.pone.0013079.g004
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splice variant compositions can result in different gene function in
neuronal tissues [25]. This is also true for QKI function. Indeed, as
previously shown by others [26] and by us [6], it is the relationship
between the splice variants that is of importance for QKI function.
The challenge for the future will be to understand the specific
functions of each splice variant and the effect of their proportions,
on other cell types in which QKI is expressed.
Among the IFN induced genes, IFIT1 and IFIT2 (also named
ISG-54 and ISG-56), are known to be highly responsive to viral
infection in CNS [27]. Mx1 and Mx2 are IFN induced resistance
factors produced by neurons, astrocytes and oligodendrocytes [28]
and they are critical components of innate immunity against a
wide range of RNA virus [29]. G1P2 (or ISG-15) is rapidly up-
regulated after intra-cerebral viral infection [30]. G1P3 (or IFI-6)
is induced by measles virus infection [31]. GBP1, or IFN-gamma-
inducible human guanylate binding protein 1, belongs to the
group of large GTP-binding proteins such as Mx [32]. GBP1 is a
key to the protective immunity against microbial and viral
pathogens and it is increased in the cerebrospinal fluid of patients
with bacterial meningitis [33]. IFIH1, or melanoma differentia-
tion associated gene-5 (MDA5), is a pathogen recognition receptor
which can, by interacting with RNA virus, initiate antiviral innate
immunity and activate genes that encode type I IFNs [34].
Therefore, the coordinated reduction of all of these genes after
QKI-7 silencing suggests a regulatory effect of this splice variant in
the IFN pathway in astrocytes. In addition, we found that
increased QKI-7 expression, induced by an antipsychotic agent,
partially reversed the effect of QKI-7 silencing, indicating that
QKI-7 levels and IFN-induced gene levels are co-regulated.
Interestingly, in a previous study performed in our group, no effect
on QKI-5 and QKI-6 was observed in treated U343 cells. In
addition, antipsychotic agents did not have an effect of QKI-7 in
oligodendrocytes. The results indicate that the effect of haloperidol
on QKI-7 is splice variant and cell type specific. All combined
results suggest a novel role for QKI-7 in astrocytes as a specific
regulator of IFN-related pathway.
Astrocytes, the most abundant glial cell population, are
important for brain homeostasis and neuronal function [35].
They display an array of receptors involved in innate immunity
and have the ability to secrete soluble mediators which have an
impact on both innate and adaptive immune responses [36].
Because of the plethora of roles to maintain central nervous system
(CNS) functions, it is not surprising that dysfunctional astrocytes
are becoming recognized as key players in many CNS disorders
[22]. Among these diseases, schizophrenia may not be an
exception. In fact, we have previously shown specific down-
regulation of QKI-7 in the prefrontal cortex (PFC) of schizophre-
nia patients [6]. In this previous work, it was not possible to
analyse the specific cell type responsible for QKI-7 down-
regulation. On the other hand, it has previously been suggested
that alterations in schizophrenia patients occur both in oligoden-
drocyte- and astrocyte-related genes [37,38]. Therefore, it is very
likely that QKI down-regulation has important physiological
consequences in both oligodendrocytes and astrocytes. All of the
results discussed here can be summarized in a testable hypothesis
related to a novel function of a specific QKI splice variant in
astrocytes. According to this hypothesis, expression of splice
variant QKI-7 regulates IFN induced gene expression in
astrocytes. When QKI-7 transcript is decreased, the innate
immune function of astrocytes is modified, making the CNS more
vulnerable to environmental insults and possibly increasing the risk
for mental disorders such as schizophrenia. This hypothesis is well
in line with previous reports discussing inflammatory components
in schizophrenia [39,40,41,42,43].
Materials and Methods
Cell Cultures
The human astrocytoma (U343) cell line was originally
established by Professor Bengt Westermark’s group [44]. The
human oligodendroglial cell line (HOG) was established from a
surgically removed human oligodendroglioma [23] and they were
kindly provided to us by Dr Campagnoni and Dr De Vellis. The
cells were cultured on six-well tissue culture plates (NUNC) in
monolayer, using Dulbecco’s Modified Eagle Medium (DMEM)
(Invitrogen, Sweden) supplemented with 5% fetal calf serum (FCS)
(Invitrogen, Sweden) and 1% penicillin-streptomycin solution
(PEST, Invitrogen, Sweden) at 37uC and 5% CO2.
RNA silencing
A pool of four siRNA duplexes was designed to silence all QKI
splice variants (QKI-tot), while two other siRNA pools were
designed to specifically silence splice variants QKI-5 or QKI-7
(DHARMACON, Custom SMARTpoolH siRNA Design). All
siRNA sequences are shown in Table 2, and the positions of the
sequences with respect to the QKI gene structure are shown in
Fig. 1A. siRNA for GAPDH (Ambion Silencer
TM GAPDH
siRNA) was used as a positive control for transfection. Also as a
control for the specificity of siRNA silencing, GAPDH silencing
did not affect expression of QKI. U343 cells were split to new six-
well tissue culture plates (NUNC) one or two days before
transfection. Transfection mix consisted of 2 ml siRNA (50 mM),
10 ml lipofectamine2000 (Invitrogen) and 588 ml OptiMEM
(Invitrogen), with a final volume of 500 ml. The negative control
(transfection mix without siRNA) contained 10 ml lipofecta-
mine2000 and 490 ml OptiMEM. The transfection and control
mix were added to cell suspensions (10
6 cells/ml) and the cell
cultures were incubated for 24 hours. Biological triplicates were
prepared for the siRNA experiment as well as the negative
controls. After 24 hours the medium was replaced with 1000 ml
fresh DMEM (without FCS and PEST) and transfected and
control cells were incubated for additional 24 hours (or more for
viability and morphology studies). The DMEM was removed from
Table 2. Sequences of duplexes designed for three siRNA cocktails used to silence all QKI splice variants (siQKI-tot) or specifically
splice variant 5 (siQKI-5) or 7 (siQKI-7).
siRNA coctail siRNA sequences
siQKI-tot GAACAGAGCAGAAAUCAAAUU GCCCGAAGCUGGUUUAAUCUU GGGAGCAUCUAAAUGAAGAUU CCAGCUGGCCCUACCAUAAUU
siQKI-5 GACAGAUGGUCCUUAACUAUU CACGUUACCUUGAUGCAAAUU GCACUUGUCCGUUCGUCUUUU GCCUACAUCUAAACACUUGUU
siQKI-7 GCAGACAUGUGUGUUGGUAUU GUGAGGAGAUUGGUAUUAGUU ACACUAAGAUUUAAACUCGUU AAUAAUAAGUGCCCAAUGAUU
doi:10.1371/journal.pone.0013079.t002
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moved to eppendorph tubes and centrifuged (2500 rpm for 5
minutes). The pellets were resuspended an additional time in
1000 ml PBS and centrifuged. The supernatant was removed and
the pellet was resuspended in 500 ml Trizol Reagent (Invitrogen)
and stored at 220uC until RNA extraction.
RNA Extraction
100 ml Chloroform was added to each of the cell samples
resuspended in trizol. All samples were mixed gently for 15 seconds,
incubated for 2–3 minutes at room temperature and centrifuged at
12000 g for 15 minutes. The aqueous phase, containing RNA, was
collected and 250 ml isopropanol was added. The tubes were
incubated for 10 minutes at room temperature and then centrifuged
at 12000 g for 10 minutes. The supernatant was removed and the
pellets were washed gently in 70% ethanol (220uC). The samples
were centrifuged at 7500 g for 5 minutes. The ethanol was removed
and the pellets were dried for 10 minutes. The RNA was dissolved in
10 ml RNase-free water. The samples were quality controlled and
quantified on a NanoDropHND-1000, and stored at 270uCu n t i lu s e .
Microarray hybridizations
About 10 mg of total RNA from each biological replicate were
used for a reverse transcription reaction with the GenisphereH
Labelling and Detection Kit, 3DNA Array 900 Cy3/Cy5. The
cDNAs produced from each silencing experiment were mixed with
cDNAs from control cells and the mix was hybridized to slides
printed with 46 k human cDNA clones (Microarray Resource
Centre, Royal Institute of Technology, Sweden). Each experiment
included three biological replicates and dye swaps. Detailed
information on the experimental design is available on ArrayEx-
press (accession number E-MEXP-1393).
Microarray Analysis
Microarrays were scanned at 10 mm resolution using a
GenePix4100A scanner (Axon Instruments, Inc.). Spots on the
resulting images were quantified with the software package
GenePix Pro 5.1 (Axon Instruments, Inc.). The mean intensity
of the two samples (Cy5-labelled sample =R, and Cy3-labelled
sampled =G) were used to calculate the log-transformed ratio
between the two samples for each spot: M=log2 (R/G). The slide
images were manually inspected and faulty spots as well as whole
faulty sections were removed from the analysis. The resulting data
was exported and the SAS statistical system was used to normalize
the slides for spatial trends (different signal intensities in different
parts of the arrays) and for red-green bias (different labeling
intensities for the two dyes). To remove spatial trends, the loess
procedure was used in both x and y direction on the arrays. Spots
with a mean intensity below their local background were excluded
and the normalized M value for missing values was set to zero.
Using the GLM procedure in SAS a statistical model was created.
In this model, the normalized R-value was the dependent variable
explained by one of the following siRNA treatments: ‘siQKI-tot’
(U343 cells treated with siRNA targeting QKI-total), ‘siQKI-5’
(U343 cells treated with siRNA targeting QKI-5) or ‘siQKI-7’
(U343 cells treated with siRNA targeting QKI-7). Penalized F was
used to identify differentially expressed genes. Permutation tests
(n=5000), in which the ID of the arrays was randomized, were
used to find appropriate cut off values for significance.
Gene Categories and gene networks
Using DAVID online tools, we tested overrepresentation of
gene ontology (GO) categories in the different lists of differentially
expressed genes after each siRNA treatment. The program
delivered a list of overrepresented categories as well as their test
statistics [45]. We studied whether QKI silencing modified
networks of related genes using ingenuity pathway analysis
(http://www.ingenuity.com/).
QRE Search
Differentially expressed genes were searched for the presence of
potential QREs in their sequences using TFBS module [46]. QRE
is a bipartite binding site separated by less than 20 base pairs. Two
QRE matrixes corresponding to each QRE half site obtained by in
vitro SELEX experiments [4] were transformed to a single pattern
weighted matrix used to perform a search for potential sites using a
Perl script. After potential core sites were identified, neighboring
sequences both upstream and downstream of these potential sites
were searched for the presence of a potential half binding sites
using a second weighted matrix. Only genes containing both a
potential core binding site and a potential half binding site were
considered as positive for the presence of a ‘‘complete QRE’’. To
test for over-representation of complete QREs in genes affected by
silencing of QKI, Fisher’s exact test was performed.
Real-Time PCR Analysis
From each biological replicate from the silencing experiments,
500 ng of total RNA was reverse transcribed to cDNA using
TaqMan RT reagents (Applied Biosystems, New Jersey). The final
concentrations of reagents were: 1 x TaqMan RT buffer, 5.5 mM
MgCl2, 2 mM dNTP mixture, 2.5 mM Oligo(dT) primers, 0.4 U/
ml RNase inhibitor and 1.25 U/ml MultiScribe reverse transcrip-
tase in RNase-free water to a total volume of 25 ml. The reaction
mix was incubated at 25uC for 10 minutes (primer annealing),
48uC for 1 hour (synthesis) and 95uC for 5 minutes (enzyme
inactivation). The resulting cDNA samples were stored at 220uC.
All real-time PCR experiments were performed on an ABI Prism
7000 Sequence Detector System (Applied Biosystems, Foster City,
USA) using 96-well plates (ABI). The TaqMan reaction mix
included 9.2 ml nuclease-free H2O, 9.8 ml TaqMan H Universal
PCR Master Mix (ABI), 0.66 ml forward primer (10 mM), 0.66 ml
reverse primer (10 mM) and 0.66 ml probe (5 mM) per sample. The
primers and probes for ACTB, GAPDH and different QKI splice
variants were described before [6]. The expression of IFIT1,
IFIT2, MX1, MX2, G1P2, G1P3, GBP1 and IFIH1 was
measured using SYBR green. Primer sequences are summarized
in Table 3. The SYBR green reactions contained 9.5 ml nuclease-
free H2O, 10 ml Power SYBR H Universal PCR Master Mix(ABI),
0.75 ml forward primer (10 mM), and 0.75 ml reverse primer
(10 mM). All reactions included 4 ml of cDNA and RNase-free
water to a total volume of 25 ml. The Real-Time PCR was
performed as follows: 50uC for 2 minutes (UNG incubation) and
95uC for 10 minutes (AmpliTaq Gold activation), followed by 40
cycles of 95uC for 10 seconds and 60uC for 1 minute. A
dissociation step was added for SYBR green runs. For each
sample, gene expression was quantified using a standard curve and
normalized against the expression of the endogenous control genes
GAPDH and ACTB. In addition, the gene expression was
normalized to a calibrator sample (untreated control cultures) to
estimate the change in gene expression after silencing. To
statistically evaluate the significance of the expression differences
two-tailed t-tests were used.
Cell viability and cell morphology
To investigate the effect that different splice variants have on
cell viability and morphology, cell cultures were silenced with
siRNA targeting QKI-5 and QKI-7, as described above. Cell
QKI Regulates Interferon Genes
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[47]. The cell body size and length of cell processes were measured
in untreated and siRNA treated cells, after one and eight days of
treatment.
Supporting Information
Figure S1 Ingenuity analysis of gene networks affected by
silencing of QKI-7. Ingenuity analysis (http://www.ingenuity.
com/) was performed to search for networks of genes affected by
QKI-7 silencing. ‘‘Cell-mediated immune response’’ is illustrated
on the left part of the figure (score 30) and ‘‘Cellular movement’’ in
the right part (score 32). Genes up-regulated by QKI-7 silencing
are marked in red and genes down-regulated by the same
treatment are marked in green. Genes not found to be affected by
QKI-7 silencing are marked in white. The microarray results
obtained for the genes marked in green and red are shown in
Supplementary Table 1, part C, where these genes are marked
with the same color. The lines connecting genes represent direct
interaction including transcriptional regulation and protein-
protein interaction between them. The shapes enclosing gene
names represent different types of factors, such as flat circles for
transcription factors.
Found at: doi:10.1371/journal.pone.0013079.s001 (0.07 MB
PDF)
Table S1 Three groups of genes changed in response to
silencing of QKI splice variants in U343 cells. The table includes
microarray expression results for genes with the most significantly
modified mRNA expression levels after silencing experiments.
Cut-off for significance was calculated as described in the methods.
Part A. Genes altered after silencing with siQKI-tot, a cocktail that
targets all splicing variants. Part B. Expression changes after
silencing with siQKI-5. Part C. Expression changes after silencing
with si-QKI-7. Genes marked with color correspond to the same
genes included in the two pathways found after the ingenuity
analysis (Fig. S1). Fold changes are given in log2 scale a Expression
changes previously reported in postmortem brains from bipolar
patients. b Expression changes previously reported in postmortem
brains from patients with schizophrenia. Data for the columns
‘‘Bipolar’’ and ‘‘Schizo’’ was extracted from the database of the
Stanley brain bank (http://www.stanleyresearch.org/brain/):
‘‘21’’, decreased mRNA expression (p value ,0.05); ‘‘1’’,
increased mRNA expression (p value ,0.05); ‘‘0’’, no significant
changes. c Number of potential QKI response elements (QRE)
contained within the transcript of the genes included in the table
calculated as described in the methods.
Found at: doi:10.1371/journal.pone.0013079.s002 (0.07 MB
PDF)
Table S2 Expression of IFN-related genes in two cell lines after
QKI-7 silencing. The table shows that all 8 IFN-related genes
were down-regulated after QKI-7 silencing of U343 cells while
their expression was not significantly affected in HOG cells.
Asterisk (*) indicates significant deviation in the mRNA levels
compared with the cells that were not treated with siQKI-7 (p-
value ,0.05, ,0.01, and ,0.001 for one, two, and three asterisks,
respectively).
Found at: doi:10.1371/journal.pone.0013079.s003 (0.01 MB
DOCX)
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